Brean Capital Reiterates Buy on Analogic (ALOG) Following 4Q - PT to $100
- Wall Street falls sharply on worries about banks
- Some Deutsche Bank (DB) Clients Said to Reduce Collateral on Trades
- Qualcomm (QCOM) in Talks to Acquire NXP Semiconductors (NXPI) - DJ
- Costco Wholesale (COST) Tops Q4 EPS by 4c; Comps Rose 3%
- After-Hours Stock Movers 09/29: (MENT) (CEMP) (COST) Higher; (CAMP) (ABUS) Lower (more...)
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Brean Capital reiterated a Buy rating on Analogic Corporation (NASDAQ: ALOG), and raised the price target to $100.00 (from $90.00), following the company's 4Q earnings report. ALOG reported revenues of $138.1 million, ahead of the consensus of $139.0 million. EPS was reported at $1.02, missing consensus by $0.15.
Analyst Jason Wittes commented, "ALOG reported F4Q16 revenues down 11% to $138.1 million versus consensus of $139.0 million (our $137.2 million), and non-GAAP EPS of $1.02 versus consensus of $1.17 (our $1.07). As anticipated, revenues were impacted by an 11% decline in security and continued atrophy of the legacy OEM probe business. Earnings quality was good, especially on the expense control line, but a higher tax rate affected non-GAAP EPS by $0.11. The company expects F2017 revenue to grow “mid-single digits with continued non-GAAP operating margin expansion targeting approximately 1 point resulting in non-GAAP earnings growth of 10% to 14%”—we are maintaining our $540 million revenue estimate (6% growth), but lowering our EPS estimate to $4.05 (at the upper end of guidance) from $4.29, mainly reflecting a higher tax rate. New guidance reflects mid-teens ultrasound growth, flat, but stable medical imaging growth and a return to double digits. We think these are reasonably conservative estimates, with good visibility and limited contribution from new growth initiatives such as Rapid DNA. Expecting a less challenging F2017, we are raising our target from $90 to $100."
Shares of Analogic Corporation closed at $89.32 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Brean Capital Assumes Akebia Therapeutics (AKBA) at Buy
- Jefferies Raises price Target on Pier 1 Imports (PIR) Following 2Q Report
- KeyBanc Starts Wal-Mart (WMT) at Overweight
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change
Related EntitiesEarnings, Brean Capital
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!